鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/02/18 | 3,595 | 3,600 | 3,535 | 3,565 | -25 | -0.7% | 42,200 |
2020/02/17 | 3,600 | 3,610 | 3,555 | 3,590 | -55 | -1.5% | 56,000 |
2020/02/14 | 3,630 | 3,680 | 3,595 | 3,645 | +40 | +1.1% | 64,200 |
2020/02/13 | 3,600 | 3,635 | 3,570 | 3,605 | +45 | +1.3% | 62,100 |
2020/02/12 | 3,600 | 3,625 | 3,560 | 3,560 | -65 | -1.8% | 76,500 |
2020/02/10 | 3,660 | 3,670 | 3,600 | 3,625 | -100 | -2.7% | 124,300 |
2020/02/07 | 3,740 | 3,805 | 3,670 | 3,725 | -85 | -2.2% | 181,600 |
2020/02/06 | 3,700 | 3,815 | 3,700 | 3,810 | +60 | +1.6% | 146,300 |
2020/02/05 | 3,765 | 3,785 | 3,695 | 3,750 | -15 | -0.4% | 71,500 |
2020/02/04 | 3,725 | 3,790 | 3,725 | 3,765 | +40 | +1.1% | 49,600 |
2020/02/03 | 3,700 | 3,760 | 3,660 | 3,725 | -10 | -0.3% | 68,200 |
2020/01/31 | 3,685 | 3,745 | 3,685 | 3,735 | ±0 | ±0% | 58,800 |
2020/01/30 | 3,800 | 3,835 | 3,730 | 3,735 | -90 | -2.4% | 67,300 |
2020/01/29 | 3,725 | 3,845 | 3,715 | 3,825 | +70 | +1.9% | 91,300 |
2020/01/28 | 3,715 | 3,795 | 3,715 | 3,755 | -20 | -0.5% | 63,800 |
2020/01/27 | 3,700 | 3,830 | 3,670 | 3,775 | +5 | +0.1% | 86,200 |
2020/01/24 | 3,770 | 3,820 | 3,710 | 3,770 | +45 | +1.2% | 97,700 |
2020/01/23 | 3,605 | 3,795 | 3,605 | 3,725 | +75 | +2.1% | 167,600 |
2020/01/22 | 3,600 | 3,650 | 3,560 | 3,650 | +80 | +2.2% | 113,800 |
2020/01/21 | 3,500 | 3,645 | 3,485 | 3,570 | +280 | +8.5% | 320,400 |
2020/01/20 | 3,255 | 3,315 | 3,250 | 3,290 | +20 | +0.6% | 44,800 |
2020/01/17 | 3,220 | 3,290 | 3,220 | 3,270 | +55 | +1.7% | 46,300 |
2020/01/16 | 3,185 | 3,215 | 3,135 | 3,215 | +30 | +0.9% | 33,500 |
2020/01/15 | 3,200 | 3,215 | 3,155 | 3,185 | -10 | -0.3% | 21,900 |
2020/01/14 | 3,260 | 3,275 | 3,170 | 3,195 | -90 | -2.7% | 48,900 |
2020/01/10 | 3,145 | 3,285 | 3,145 | 3,285 | +175 | +5.6% | 85,000 |
2020/01/09 | 3,070 | 3,110 | 3,060 | 3,110 | +85 | +2.8% | 29,100 |
2020/01/08 | 3,000 | 3,045 | 2,924 | 3,025 | ±0 | ±0% | 57,600 |
2020/01/07 | 3,010 | 3,035 | 2,994 | 3,025 | +15 | +0.5% | 19,700 |
2020/01/06 | 3,015 | 3,030 | 2,994 | 3,010 | -50 | -1.6% | 35,600 |
2019/12/30 | 3,045 | 3,075 | 3,020 | 3,060 | +10 | +0.3% | 25,700 |
2019/12/27 | 2,952 | 3,050 | 2,952 | 3,050 | +59 | +2% | 44,400 |
2019/12/26 | 2,973 | 2,991 | 2,956 | 2,991 | +10 | +0.3% | 16,000 |
2019/12/25 | 2,991 | 2,998 | 2,972 | 2,981 | -10 | -0.3% | 8,900 |
2019/12/24 | 3,030 | 3,035 | 2,982 | 2,991 | -5 | -0.2% | 17,200 |
2019/12/23 | 3,030 | 3,030 | 2,996 | 2,996 | -24 | -0.8% | 12,200 |
2019/12/20 | 3,035 | 3,035 | 2,990 | 3,020 | -15 | -0.5% | 25,100 |
2019/12/19 | 3,015 | 3,035 | 2,994 | 3,035 | +53 | +1.8% | 20,800 |
2019/12/18 | 3,015 | 3,035 | 2,966 | 2,982 | -33 | -1.1% | 39,900 |
2019/12/17 | 2,998 | 3,030 | 2,998 | 3,015 | +28 | +0.9% | 41,400 |
2019/12/16 | 2,950 | 2,988 | 2,940 | 2,987 | +47 | +1.6% | 62,800 |
2019/12/13 | 2,938 | 2,960 | 2,910 | 2,940 | +49 | +1.7% | 69,100 |
2019/12/12 | 2,949 | 2,959 | 2,880 | 2,891 | -62 | -2.1% | 55,400 |
2019/12/11 | 2,964 | 2,991 | 2,940 | 2,953 | -4 | -0.1% | 46,800 |
2019/12/10 | 2,935 | 2,969 | 2,913 | 2,957 | +12 | +0.4% | 38,600 |
2019/12/09 | 2,899 | 2,949 | 2,891 | 2,945 | +59 | +2% | 60,100 |
2019/12/06 | 2,900 | 2,918 | 2,880 | 2,886 | -28 | -1% | 39,400 |
2019/12/05 | 2,900 | 2,920 | 2,885 | 2,914 | +9 | +0.3% | 38,200 |
2019/12/04 | 2,850 | 2,905 | 2,845 | 2,905 | +35 | +1.2% | 40,000 |
2019/12/03 | 2,840 | 2,880 | 2,840 | 2,870 | +19 | +0.7% | 34,300 |
1351~
1400
件表示中 / 3769件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
ペプチド | 154,000円 | +5.0% | +1.5% | 0.00% | 13.18倍 | 3.71倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 426,500円 | +3.6% | - | 2.81% | 14.37倍 | 0.85倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サンバイオ | 239,600円 | - | - | 0.00% | - | 110.98倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
科研薬 | 385,500円 | -6.4% | -71.8% | 4.93% | 42.93倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム